FISOGNI, Simona
 Distribuzione geografica
Continente #
NA - Nord America 835
EU - Europa 467
AS - Asia 239
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.542
Nazione #
US - Stati Uniti d'America 832
PL - Polonia 124
CN - Cina 109
DE - Germania 104
UA - Ucraina 82
SG - Singapore 48
IT - Italia 45
FI - Finlandia 35
HK - Hong Kong 30
GB - Regno Unito 25
TR - Turchia 17
IE - Irlanda 16
FR - Francia 13
RU - Federazione Russa 13
IN - India 12
VN - Vietnam 12
CZ - Repubblica Ceca 5
ID - Indonesia 3
CA - Canada 2
IL - Israele 2
IR - Iran 2
AE - Emirati Arabi Uniti 1
BE - Belgio 1
ES - Italia 1
EU - Europa 1
JM - Giamaica 1
KR - Corea 1
MK - Macedonia 1
MY - Malesia 1
NL - Olanda 1
OM - Oman 1
SE - Svezia 1
Totale 1.542
Città #
Warsaw 124
Woodbridge 118
Fairfield 115
Ashburn 73
Jacksonville 67
Houston 58
Seattle 44
New York 38
Singapore 38
Ann Arbor 34
Cambridge 33
Wilmington 32
Hong Kong 30
Princeton 30
Chandler 29
Helsinki 28
Beijing 25
Dearborn 25
Dublin 16
Istanbul 15
Brescia 13
Dong Ket 12
Lancaster 12
Los Angeles 12
Nanjing 12
Nanchang 11
Shanghai 10
Des Moines 9
Munich 8
Nürnberg 7
San Mateo 6
Shenyang 6
Changsha 5
Hefei 5
Jinan 5
Monmouth Junction 5
Brno 4
Hangzhou 4
Hebei 4
Jiaxing 4
London 4
Pisa 4
San Diego 4
Tavernola Bergamasca 4
Tianjin 4
Jakarta 3
Mumbai 3
Rome 3
Ardabil 2
Carmignano 2
Kilburn 2
Kunming 2
Orange 2
San Francisco 2
Taizhou 2
Toronto 2
Torrita 2
Verona 2
Zhengzhou 2
Amsterdam 1
Augusta 1
Bengaluru 1
Boardman 1
Brussels 1
Cairate 1
Chicago 1
Frankfurt am Main 1
Gatchina 1
Guangzhou 1
Haifa 1
Islington 1
Kocaeli 1
Lanzhou 1
Leawood 1
Lincoln 1
Miami Beach 1
Milan 1
Murcia 1
Muscat 1
Ningbo 1
Norwalk 1
Olomouc 1
Palermo 1
Prescot 1
Romola 1
Skopje 1
Swindon 1
Villa di Briano 1
Walnut 1
Washington 1
Totale 1.208
Nome #
Positive Surgical Margins Predict Progression-free Survival After Nephron-sparing Surgery for Renal Cell Carcinoma: Results From a Single Center Cohort of 459 Cases With a Minimum Follow-up of 5 Years 151
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 149
DISCRIMINATION ABILITY OF THE SURFACE-INTERMEDIATE-BASE MARGIN (SIB) SCORE: AN EXTERNAL HISTOPATHOLOGICAL EVALUATION 139
PATHOGENESIS, FEATURES AND PROGNOSIS OF RENAL RELAPSE AFTER PARTIAL NEPHRECTOMY 126
PATHOGENESIS, FEATURES AND PROGNOSIS OF RENAL RELAPSE AFTER PARTIAL NEPHRECTOMY 126
Features of Ipsilateral Renal Recurrences After Partial Nephrectomy: A Proposal of a Pathogenetic Classification 125
External histopathological validation of the surface-intermediate-base margin score 122
Intrafollicular Epstein-Barr virus-positive large B cell lymphoma. A variant of “germinotropic” lymphoproliferative disorder 117
DISCRIMINATION ABILITY OF TH SURFACE-INTERMEDIATE-BASE MARGIN :(SIB) SCORE: AN EXTERNAL HISTOPATHOLOGICAL EVALUATION 106
Standard vs delayed ligature of the dorsal vascular complex during robot-assisted radical prostatectomy: results from a randomized controlled trial 101
Positive surgical margins and early oncological outcomes of robotic versus open radical prostatectomy at a medium case-load institution 93
Single Cell Analysis of Circulating Endothelial Cells in Allogeneic Hematopoietic Stem Cell Transplant; To Whom Do They Belong: Host or Donor? 77
Nuclear bubbles (Nuclear Pseudo-Pseudoinclusions): A pitfall in the interpretation of microscopic sections from the thyroid and other human organs 62
POSITIVE SURGICAL MARGINS PREDICT PROGRESSION-FREE SURVIVAL AFTER NEPHRON SPARING SURGERY FOR RENAL CELL CARCINOMA: RESULTS FROM A SINGLE CENTRE COHORT OF ALMOST 500 CASES WITH A MINIMUM FOLLOW_UP OF 5 YEARS 46
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets 25
Pathological Complete Response to Pembrolizumab plus Axitinib Combination following Serious Immune-Related Adverse Events in an Advanced Renal Cell Carcinoma Patient with a History of Rheumatoid Arthritis 13
Totale 1.578
Categoria #
all - tutte 7.026
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.026


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020320 0 0 0 0 21 52 46 43 33 71 22 32
2020/2021298 9 30 9 51 10 30 12 29 30 33 32 23
2021/2022118 13 6 6 3 2 5 3 10 5 18 13 34
2022/202395 17 2 7 1 8 24 0 10 15 1 5 5
2023/2024206 16 7 9 21 15 49 3 11 34 9 2 30
2024/202589 3 2 1 54 29 0 0 0 0 0 0 0
Totale 1.578